SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-007820
Filing Date
2022-05-05
Accepted
2022-05-05 16:09:15
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-20220505.htm   iXBRL 8-K 53979
2 EX-99.1 vir-ex99_1.htm EX-99.1 350652
3 GRAPHIC img127984614_0.jpg GRAPHIC 5507
  Complete submission text file 0000950170-22-007820.txt   552321

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20220505.xsd EX-101.SCH 2486
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20220505_lab.xml EX-101.LAB 12936
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20220505_pre.xml EX-101.PRE 9580
8 EXTRACTED XBRL INSTANCE DOCUMENT vir-20220505_htm.xml XML 4536
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 22896293
SIC: 2836 Biological Products, (No Diagnostic Substances)